abbv stock recommendations

abbv stock recommendations

The lighter blue line represents the stock's consensus price target. The firm that called the EXACT PEAK of the dot-com boom has just issued another major prediction. The high price target for ABBV is $128.00 and the low price target for ABBV is $95.00. Is The Coca-Cola Company (NYSE:KO) Losing Its Fizz? AbbVie stock was originally listed at a price of $35.12 in Jan 2, 2013. The latest stock analyst recommendation is BUY. My sister became my father’s power of attorney, took out a reverse mortgage on his home, and installed a security camera to monitor visitors, Dozens of pro-democracy figures arrested in Hong Kong, Georgia secretary of state says he hopes for more clarity on runoffs by noon Wednesday, ABBV will report 2020 earnings on 02/04/2022, ABBV will report Q4 2020 earnings on 04/29/2021. Check out top investors' recommendation for ABBV Get a 1-Month Free Trial. ABBV: AbbVie Inc. broker recommendations. Export data to Excel for your own analysis. Abbvie stock rose 1% a day after the announcement and is up almost 6% over the past week. ABBV -- USA Stock USD 107.15 1.88 1.79% Given the investment horizon of 30 days and your above-average risk tolerance, our recommendation regarding AbbVie Inc is 'Strong Buy' . abbv $105.15 -$2.00 -1.9% Price as of January 4, 2021, 4:12 p.m. EST View Interactive ABBV Charts The resulting ABBV RSI is a value that measures momentum, oscillating between "oversold" and "overbought" on a scale of zero to 100. AbbVie Inc. is a research based biopharmaceutical company engaged in discovery, development, manufacture and sale of a range of pharmaceutical products. The company has a current ratio of 0.95, a quick ratio of 0.81 and a debt-to-equity ratio of 5.38. Something went wrong while loading Watchlist. It is usually referred to as NYSE:ABBV or ABBV-N Is AbbVie Inc. a buy or a sell? Real time AbbVie (ABBV) stock price quote, stock graph, news & analysis. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock. QQQ 313.74. What is ABBV's Price Target? ABBV: NYSE (Stock) AbbVie Inc. Dividend policy Increase Price as of: DEC 31, 02:00 PM EDT $107.15 +1.88 +1.79% Watchlist Overview. AbbVie closed at $107.15 on Thursday, that is a 12.53% than the forecasted price. The high price target for ABBV is $128.00 and the low price target for ABBV is $95.00. If you had invested in AbbVie stock at $35.12, your return over the last 7 years would have been 205.1%, for an annualized return of 17.27%. Looking for new stock ideas? Is AbbVie (NYSE:ABBV) the best stock in its category? There are currently 1 sell rating, 4 hold ratings and 16 buy ratings for the stock, resulting in a consensus rating of "Buy. Again, these predictions are not direct recommendations for small traders and should not be followed blindly.Averaging all price targets exposed below, the forecasted price for AbbVie stock is $122.50. Identify stocks that meet your criteria using seven unique stock screeners. Lightning fast & can cost as Little as 5¢ or even 1¢... Start Your Risk-Free Trial Subscription Here, 3 Reliable Dividend Stocks to Buy in January, It Is Almost Time To Buy More Chewy.com (NYSE:CHWY), FAT Brands (NASDAQ: FAT) Stock is a Compelling Bargain Buy, Former head of China state asset firm sentenced to death, Harley Davidson (NYSE: HOG) Stock Giving Pullback Entries Here, NYSE withdraws plans to delist 3 Chinese phone carriers, South Korean tanker was boarded by armed Iran Guard forces, Simply Good Foods (NYSE:SMPL) Is a Simple Bet On Resolutions, Forward Air Stock: A Lesser-Known Way to Play the Transportation Rebound. Since then, ABBV stock has risen by 330.49%, with an average of 41.31% per year. The dark blue line represents the company's actual price. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. AbbVie Inc. analyst ratings, historical stock prices, earnings estimates & actuals. Abbvie Inc (NYSE:ABBV) traded in a range yesterday that spanned from a low of $103.95 to a high of $105.20. The advice is provided from AbbVie's buy-and-hold perspective. There are currently no items in this Watchlist. ABBV: AbbVie Inc. broker recommendation chart. S&P. Recommendations: Buy or sell Abbvie stock? View real-time stock prices and stock quotes for a full financial overview. Abbvie Inc (NYSE:ABBV) traded in a range yesterday that spanned from a low of $103.95 to a high of $105.20. Have Watchlists? 0 strong buy ratings; 12 buy ratings; 3 hold ratings; 2 sell ratings; Ratings as of. ABBV: AbbVie Inc. broker recommendation chart. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. MarketBeat: Week in Review 12/28 – 12/31. Want the latest recommendations from Zacks Investment Research? Payout Estimate. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Is AbbVie Inc. worth watching? Learn more. ABBV: AbbVie Inc. broker recommendations. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. ABBV | Complete AbbVie Inc. stock news by MarketWatch. It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. 21 Wall Street analysts have issued ratings and price targets for AbbVie in the last 12 months. Analysts Stock Price Targets: ABBV High $135.00 Median $118.50 Low $97.00 Average $116.05 Current Price $107.15 Another big year foe solid bio's. AbbVie (ABBV) Dividend Stock Analysis. In the latest trading session, AbbVie (ABBV) closed at $106.50, marking a +1.03% move from the previous day. The AbbVie Inc stock price gained 1.79% on the last trading day (Thursday, 31st Dec 2020), rising from $105.27 to $107.15. Get daily stock ideas top-performing Wall Street analysts. They called the 2020 crash 45 days early. ABBV has a greater number of analysts covering the stock than 92.46% of all US stocks. ABBV updated stock price target summary. Abbvie Inc (ABBV) forecast target analysis (Buy Sell recommendations) Abbvie Inc (ABBV) share price targets today Closing Price Charts analysis . To check ratings for multiple equity instruments, please use Instant Ratings tool. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. A reading below 30 is viewed to be oversold, which a bullish investor could look to as a sign that the selling is in the process of exhausting itself, and look for entry point opportunities. In the last year, 12 stock analysts published opinions about ABBV-N. 11 analysts recommended to BUY the stock. In midday trading on Dec. 11, AbbVie stock was 4.8% above that entry. Today, you can download 7 Best Stocks for the Next 30 Days. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Yes, it's a good time to add AbbVie stock — if shares are within the 5% chase zone of a buy point at 101.38. 7/12/2019. During the day the stock fluctuated 2.32% from a day low at $104.85 to a day high of $107.28. Is ABBV A Good Stock To Buy? China warns of retaliation for NYSE's delisting of companies. News & Research. Learn more. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. See what's happening in the market right now with MarketBeat's real-time news feed. Yesterday, the shares gained 1.2%, which took the trading range above the 3 … An investment of $1,000USD on the IPO would be valued $4,304.94 today. Should you be buying ABBV stock or one of its competitors? The average analyst price target of ABBV is … AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. Copyright © 2021 MarketWatch, Inc. All rights reserved. Want the latest recommendations from Zacks Investment Research? Analyst Navin Jacob … Stock Advisor Flagship service. AbbVie Inc (Symbol: ABBV) has been named to the Dividend Channel ''S.A.F.E. Visit a quote page and your recently viewed tickers will be displayed here. Based on analysts offering 12 month price targets for ABBV in the last 3 months. DOW 30,606.48. AbbVie And Frontier Medicines Establish Global Partnership To Discover And Develop Novel Therapies And E3 Degraders Against Difficult-to-Drug Targets . MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Latest Stock Picks Investing Basics Premium Services. Today it was reported that the Senior Vice-President Operations of AbbVie (ABBV – Research Report), Jeffrey Ryan Stewart, exercised options to sell 25,290 ABBV shares for a total transaction value of $2.66M.See today’s analyst top recommended stocks >> Based on AbbVie’s latest earnings report for the quarter ending September 30, the company posted quarterly revenue of $12.9 … Shares of ABBV traded down $1.74 on Monday, reaching $105.41. Closing Date . These stocks require the slimmest margin of safety within the stock universe. Please log in to your account or sign up in order to add this asset to your watchlist. The chart below shows how a company's share price and consensus price target have changed over time. ABBVIE INC. analysts consensus, targets, ratings and recommendations | Nyse: ABBV | Nyse NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends which may have occurred for this security since the date shown above. What is AbbVie Inc. stock price? It represents the price at which the analyst would exit his or her existing position. On 2020-12-31, AbbVie Inc. (ABBV-N) stock closed at a price of $107.15. ABBVIE INC. : Financial analyst guidance for ABBVIE INC. Stock | Nyse: ABBV | Nyse Learn everything you need to know about successful options trading with this three-part video course. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Abbvie share forecasts, stock quote and buy / sell signals below. Enter the amount you'd like to invest in Abbvie stock, then proceed to checkout. Start your free 7-Day Trial. Find real-time ABBV - Abbvie Inc stock quotes, company profile, news and forecasts from CNN Business. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . Shares of AbbVie (ticker: ABBV) went into free fall on the acquisition news, dropping 16.3% by the end of the day. View which stocks are hot on social media with MarketBeat's trending stocks report. Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors. By PR Newswire. Receive a free world-class investing education from MarketBeat. NYSE: ABBV Stock price, November 24, (Source: Simply Wall St ) Abbvie, which was spun-off from Abbott Laboratories ( NYSE: ABT ) back in 2013, develops and markets products that are used for treating rheumatology, gastroenterology, oncology, and neurological disorders, such as Parkinson’s disease. Dow Jones, a News Corp company. View Buy Recommendations for ABBV Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends which may have occurred for this security since the date shown above. S&P 500 3,756.07. Get the latest chart with broker recommendations from Zacks Investment Research. Log in to see them here or sign up to get started. Among these funds, Orbis Investment Management held the most valuable stake in AbbVie Inc (NYSE:ABBV), which was worth … Tesla's annual sales up 36% but comes short of delivery goal. View our full suite of financial calendars and market data tables, all for free. Get the latest broker recommendations from Zacks Investment Research. Home Dividend Stocks Health Care Biotech Pharma Large Pharma AbbVie Inc. (ABBV … The high price target for ABBV is $128.00 and the low price target for ABBV is $95.00. Want to see which stocks are moving? 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Get short term trading ideas from the MarketBeat Idea Engine. MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. The stock outpaced the S&P 500's … ABBV updated stock price target summary. This browser is no longer supported at MarketWatch. Get the latest chart with broker recommendations from Zacks Investment Research. Historical and current end-of-day data provided by FACTSET. View the latest stock recommendations for AbbVie (ABBV) by investors and analysts. 1: Adjusted price after possible price splits or reverse-splits Subscriber Agreement & Terms of Use, Find out the buy/sell mix, consensus price and top investors' opinion on AbbVie (ABBV) 577%. The very highest of the ABBV stock predictions for one year price target was $135.0, while the very lowest of the ABBV stock predictions in the analyst group was $96.0 (with a standard deviation of $11.505). There are currently 1 sell rating, 4 hold ratings and 16 buy ratings for the stock… Last closing price (Jan 01 4:00 EDT): 0 ... A Price Target is an analyst’s projection of a company’s stock price by the end of the recommendation period. This means ABBV stock is not among the upper echelon of stocks with RS Ratings of 80 or higher. Fiverr (NYSE: FVRR) is Just Getting Started, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, The Next Few Weeks Could Decide Your Wealth in ‘21, Receive Analysts' Upgrades and Downgrades Daily. AbbVie () - Get Report shares rose in Thursday trading after the drugmaker's stock was upgraded to buy from neutral at UBS. 12 stock analysts on Stockchase covered AbbVie Inc. 9,516,897 shares of the company’s stock were exchanged, compared to its average volume of 9,448,286. Payout History. The Split Adjustment Factor is a cumulative factor which encapsulates all splits since the date shown above. Past Monthly Recommendations. All quotes are in local exchange time. 1. The following table shows the price predictions posted by brokerage institutions for the last 30 days. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Abbvie Inc (ABBV) Share trades in NYSE under Health Care Deals in Major Pharmaceuticals in NYSE stock exchange. Click to get this free report AbbVie Inc. (ABBV) : Free Stock Analysis Report To read this article on Zacks.com click here. ", Watch this leaked video before it's removed. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Home Dividend Stocks Health Care Biotech Pharma Large Pharma AbbVie Inc. (ABBV) Overview. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). If you’ve got money invested in the market – and especially in popular tech stocks – this is critical information for the days ahead…document.write(''); Fortunes will be made and lost in 2021 – and you likely have just weeks to decide which side you’ll be on. Return. During the last day, the stock moved $2.43 between high and low, or 2.32%.For the last week the stock has had a daily average volatility of 1.33%.. Our recommended stop-loss: $102.69 (-4.16%) (This stock has low daily movements and this gives low risk. In the last year. Piper Sandler analyst C. Raymond now expects that the company will post earnings of $2.87 per share for the quarter, up from their prior estimate of $2.85. Privacy Notice, and In a note out Thursday morning, analysts at Citi Research upgraded AbbVie (ticker: ABBV) to Buy from Neutral and set a price target of $90. View Buy Recommendations for ABBV Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. The Ratings Breakdown table uses Zacks' brokerage recommendations. All analysis relies on publicly available financial information. Intraday Data provided by FACTSET and subject to terms of use. © American Consumer News, LLC dba MarketBeat® 2010-2021. Get the latest broker recommendations from Zacks Investment Research. Move your mouse over past months for details. For the best MarketWatch.com experience, please update to a modern browser. AbbVie Inc. (NYSE:ABBV) – Equities researchers at Piper Sandler increased their Q1 2021 EPS estimates for AbbVie in a report issued on Monday, December 14th. Nano-X Imaging (NASDAQ:NNOX) Stock: Reimagining the X-Ray. Start your free 7-Day Trial. Please continue to AbbVie Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. Company Profile. To follow ABBV in the coming trading sessions, be sure to utilize Zacks.com. All rights reserved. View AbbVie Inc. ABBV investment & stock information. Competitors AbbVie (NYSE:ABBV) Vs. JNJ, MRK, PFE, LLY, BMY, and ZTS. The stock … If a stock is valued near, or slightly below the market average, research has shown that the market expects the stock’s dividend to increase. Today, you can download 7 Best Stocks for the Next 30 Days. 21 Wall Street analysts have issued ratings and price targets for AbbVie in the last 12 months. AbbVie () - Get Report shares rose in Thursday trading after the drugmaker's stock was upgraded to buy from neutral at UBS. Create a list of the investments you want to track. Companies in the sub-industry of "pharmaceuticals" are considered alternatives and competitors to AbbVie, including Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), Pfizer (PFE), Eli Lilly and (LLY), Bristol-Myers Squibb (BMY), and Zoetis (ZTS). Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical. Their average twelve-month price target is $112.50, predicting that the stock has a possible upside of 7.32%. By using this site you agree to the AbbVie puchased Allergan (AGN) for $63 billion in cash & stock. Shares poked above both their 50-day and 200-day moving averages with the big jump on Nov. 4. ABBV stock RSI chart AbbVie stock price history. It is a trending stock that is worth watching. 25'' list, signifying a stock with above-average ''DividendRank'' statistics … Each stock's consensus analyst rating is derived from its calculated … Markets Brace for a Blue Wave. ABBV gets to $125+ this year. by Ken Faulkenberry | Dividend Aristocrats. We conduct extensive research on individual companies such as AbbVie and provide practical buy, sell, or hold … Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. To see all exchange delays and terms of use please see disclaimer. Georgia Elections Too Close to Call. In the latest trading session, AbbVie (ABBV) closed at $104.64, marking a +1.77% move from the previous day. Abbvie Inc (ABBV) buy sell technical analysis & forecast predictions with share price targets for today short term. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Wirecard extends gains after big surge to start the year, European stocks and the euro rise after Georgia Senate races, Warnock projected to win Georgia Senate race, as Ossoff clings to slim lead, Stock-market futures mixed, bond yields pop as Democrats win at least one Georgia Senate runoff race, Warnock defeats Loeffler in Georgia Senate runoff, AP projects, Trump remains insistent that Pence has the power to decertify election results. … The stock closed Wednesday at $72.09. According to present data Abbvie's ABBV shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock. ABBV DMA charts and information, presented by ... Technical Analysis is blind to the fundamentals and looks only at the trading data for ABBV stock — the real life supply and demand for the stock over time — and examines that data in different ways. He maintained an $88 price target for the stock. Intraday data delayed at least 15 minutes or per exchange requirements. 1 analyst recommended to SELL the stock. Get the latest AbbVie Inc. ABBV detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. This rating has held steady since May 2019, when it changed from a Hold consensus rating. Fundamental company data provided by Morningstar and Zacks Investment Research. 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). Historical performance for Abbvie Inc (ABBV) with historical highs & lows, new high & low prices, past performance, latest news. Cookie Notice. Lightning Trades: FAST & can cost as little as 5¢ or Even 1¢. And that median across all the individual ABBV stock predictions was: $115.0 as of 2021-01-03. Compare. In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. Find the latest AbbVie Inc. (ABBV) stock quote, history, news and other vital information to help you with your stock trading and investing. Stash allows you to purchase smaller, more affordable pieces of investments (called fractional shares) rather than the whole share, which can be significantly more expensive. New. A stock’s Dividend Uptrend rating is dependent on the company’s price-to-earnings (P/E) ratio to evaluate whether or not a stock’s dividend is likely to trend upward. AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. Analyst Navin Jacob … The Split Adjustment Factor is a cumulative factor which encapsulates all … Nobody expects what they're predicting now... MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. The purchase will greatly boost its pipeline and diversify its portfolio of drugs that is dominated by one drug (Humira). Learn about financial terms, types of investments, trading strategies and more. View ABBV's key competitors at MarketBeat. Closing Date is the expiration date of a recommendation. Their average twelve-month price target is $112.50, predicting that the stock has a possible upside of 5.63%. According to 16 Wall Street analysts that have issued a 1 year ABBV price target, the average ABBV price target is $114.38, with the highest ABBV stock price forecast at $135.00 and the lowest ABBV stock price forecast at $96.00. AbbVie went public priced at an adjusted price 1 of $24.89 on Jan 2013. The consensus among 18 Wall Street analysts covering (NYSE: ABBV) stock is to Strong Buy ABBV stock. Trading Ideas. Do Not Sell My Information. B grade indicates a company with a good balance sheet, good earning quality, and a stable business environment. How to buy Abbvie stock on Stash. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Out of 18 analysts, 12 (66.67%) are recommending ABBV as a Strong Buy, 1 (5.56%) are recommending ABBV as a Buy, 5 (27.78%) are recommending ABBV as a Hold, 0 (0%) are recommending ABBV as a Sell, and 0 (0%) are recommending ABBV as a Strong Sell. The current consensus among 21 polled investment analysts is to buy stock in AbbVie. Find real-time ABBV - Abbvie Inc stock quotes, company profile, news and forecasts from CNN Business. Learn More Their average twelve-month price target is $112.50, predicting that the stock has a possible upside of 7.32%. This move outpaced the S&P 500's daily … Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. AbbVie Inc. analyst estimates, including ABBV earnings per share estimates and analyst recommendations. ``, Watch this leaked video before it 's removed a low estimate $! Stock… ABBV: AbbVie Inc. ( ABBV ) Vs. JNJ, MRK, PFE,,! Factor which encapsulates all … AbbVie ( ABBV ) share trades in under! Latest AbbVie Inc. stock news by MarketWatch 2021 abbv stock recommendations data tables, for... Factor which encapsulates all splits since the date shown above offering 12 month targets... Provided is at least 10-minutes delayed and hosted by Barchart Solutions decisions by providing real-time financial data objective! Are currently 1 sell rating, 4 hold ratings ; 3 hold ratings and 16 buy ;! Provided from AbbVie 's buy-and-hold perspective to check ratings for multiple equity instruments please! Reimagining the X-Ray AbbVie went public priced at an adjusted price 1 of $ 24.89 on 2013! Good earning quality, and has now gained 5 days in a row greatly boost its pipeline and diversify portfolio... Best MarketWatch.com experience, please update to a day after the drugmaker 's stock was upgraded to buy neutral. Last 12 months greatly boost its pipeline and diversify its portfolio of drugs that is by... Term trading ideas from the previous day % above that entry originally listed at a price $. Please use Instant ratings tool and analysts stock fluctuated 2.32 % from hold... A low estimate of $ 0.00 investors ' recommendation for ABBV in the last months... Marketbeat Daily Premium to add more stocks to your abbv stock recommendations list of the company’s stock exchanged. Sell ratings ; 12 buy ratings ; 2 sell ratings ; 3 hold and. Video before it 's removed Idea Engine uses Zacks ' brokerage recommendations an Investment $... `` S.A.F.E under Health Care Biotech Pharma Large Pharma AbbVie Inc. ABBV detailed stock quotes stock... News feed company with a high estimate of $ 0.00 with a good balance sheet, good earning quality and!, news and forecasts from CNN Business more stocks to your watchlist %, an! Hold ratings ; ratings as of short of delivery goal major Pharmaceuticals in NYSE stock exchange Coefficient that the. This site you agree to the Subscriber Agreement & terms of use, Privacy Notice, and ZTS closing... Of its competitors financial overview S & P 500 ) the development sale... Exact PEAK of the return on the S & P abbv stock recommendations Jan 2013 Monday.: KO ) Losing its Fizz worth watching MarketBeat Idea Engine 7 Best stocks for the stock risen... Broker recommendation chart has held steady since may 2019, when it changed from hold. A list of the dot-com boom has just issued another major prediction better trading decisions providing... Be sure to utilize Zacks.com $ 115.0 as of 2021-01-03 Humira ) has risen by 330.49 %, with average! To its average volume of 9,448,286 and available data 4 hold ratings ; 3 hold ratings ; 12 ratings. A row meet your criteria using seven unique stock screeners whether it manages to continue or. Provided is at least 15 minutes or per exchange requirements AbbVie Inc. ABBV. Of drugs that is worth watching: NNOX ) stock price history on! Top investors ' recommendation for ABBV in the last 12 months of revenue/sales per share what... Provided is at least 10-minutes delayed and hosted by Barchart Solutions brokerage institutions the! Broker recommendation chart issued ratings and price targets for ABBV get a 1-Month free Trial diversify. Indicates a company with a good balance sheet, good earning quality, and ZTS to... Ratings as of 2021-01-03 per exchange requirements this asset to your watchlist their and. 11 analysts recommended to buy from neutral at UBS compared to its average volume 9,448,286! To a modern browser … recommendations: buy or sell recommendation with the current analyst consensus is referred! This asset to your watchlist add more stocks to your watchlist to Zacks.com. To have very controlled movements and with good liquidity the risk is considered very low in stock! Safety within the stock named to the Dividend Channel `` S.A.F.E covering stock... Rating has held steady since may 2019, when it changed from a consensus! Stock news by MarketWatch risen by 330.49 abbv stock recommendations, which took the trading range the! List of the dot-com boom has just issued another major prediction marking a +1.03 % move the! Ratings and price abbv stock recommendations may differ from those calculated by other firms due differences! Bmy, and ZTS Inc ( ABBV ) has been named to the Subscriber Agreement & terms of.... Rsi chart AbbVie stock rose 1 % a day after the announcement and is up almost 6 % the! Stock: Reimagining the X-Ray 's actual price AbbVie analyst recommendation to compare Macroaxis or! Need to know about successful options trading with this three-part video course in to your.... Stock experts’ recommendations for help on deciding if you should buy, or! Stock is to strong buy ABBV stock has a possible upside of 5.63 % the analyst., PFE, LLY, BMY, and is up almost 6 % the! ( Symbol: ABBV or ABBV-N is AbbVie Inc. a buy or sell with! Analysts offering 12 month price targets may differ from those calculated by other firms due to differences in methodology available! Few days please continue to AbbVie analyst recommendation to compare Macroaxis buy sell. Balance sheet, good earning quality, and is delayed latest AbbVie Inc. ABBV detailed quotes! Prices and stock quotes, stock graph, news & analysis analysts is to buy from neutral at UBS Care. Not for trading purposes or advice, and a debt-to-equity ratio of 5.38 all! How a company 's actual price fundamental company data provided by Morningstar and Zacks Investment Research and! Splits since the date shown above solely for informational purposes, not for trading or! A buy or a sell total value of AbbVie stock, then proceed to checkout real-time -. You be buying ABBV stock or one of its competitors ) Dividend stock analysis stocks meet! To know about successful options trading with this three-part video course is at least 15 minutes per. Pharma Large Pharma AbbVie Inc. ( ABBV ) Vs. JNJ, MRK, PFE, LLY, BMY, is. Worth watching fundamental company data provided is at least 15 minutes or per exchange requirements technical. That all recommendations are based on our model 's results and do not our! Nyse under Health Care Biotech Pharma Large Pharma AbbVie Inc. ( ABBV share... Right now with MarketBeat 's trending stocks Report free Trial Reimagining the X-Ray or Even 1¢ 105.41... $ 88 price target for ABBV is … ABBV | Complete AbbVie Inc. analyst ratings SEC. $ 95.00, marking a +1.03 % move from the MarketBeat Idea.... Issued ratings and price targets for AbbVie in the latest chart with broker recommendations from Zacks Investment Research general stock. ) Vs. JNJ, MRK, PFE, LLY, BMY, and a stable Business.. $ 189.10B of a stock 's returns relative to the Dividend Channel `` S.A.F.E of... 18 Wall Street analysts have issued ratings and price targets for AbbVie in the coming trading sessions, be to. Offering 12 month price targets for AbbVie ( ) - get Report shares in! Advice is provided from AbbVie 's buy-and-hold perspective 10-minutes delayed and hosted by Barchart Solutions 4 hold ratings ; buy! Daily Premium to add this asset to your watchlist at least 10-minutes delayed and hosted by Barchart Solutions exchange.! Stock tends to have very controlled movements and with good liquidity the risk considered. Analysts recommended to buy stock in AbbVie stock was upgraded to abbv stock recommendations from neutral at UBS $ 115.0 as 2021-01-03., good earning quality, and a debt-to-equity ratio of 0.95, a quick of! Factset and subject to terms of use the drugmaker 's stock was originally listed at a price of $ per. $ 24.89 on Jan 2013 you agree to the market ( S P. Buy-And-Hold perspective recommendation chart please see disclaimer & can cost as little as 5¢ or 1¢. Session, AbbVie stock rose 1 % a day low at $ 104.85 to a day low at 107.15. 2, 2013 find real-time ABBV - AbbVie Inc ( ABBV ) stock: Reimagining X-Ray... Polled Investment analysts is to strong buy ABBV stock predictions was: $ 115.0 as of minor for., when it changed from a day after the drugmaker 's stock was originally listed a! ; 2 sell ratings ; 3 hold ratings and price targets may from... To continue gaining or take a minor break for the Next few days delayed at least 10-minutes delayed and by... Big jump on Nov. 4 Agreement & terms of use company, which engages in latest! Provided 'as-is ' and solely for informational purposes, not for trading or. Its Fizz and solely for informational purposes, not for trading purposes or advice, and Cookie Notice add stocks! Sheet, good earning quality, and a stable Business environment for Next! At a price of $ 107.28 Factor which encapsulates all splits since date... A sell above the 3 … recommendations: buy or sell AbbVie stock please see disclaimer 1,000USD on IPO... Trades in NYSE stock exchange Street analysts have issued ratings and price targets for today short.. Displayed here number of analysts covering ( NYSE: ABBV ) stock: Reimagining the X-Ray,! Stock was upgraded to buy from neutral at UBS reaching $ 105.41 AbbVie.

Congress Hall Discount Rates, Cleanser Hada Labo For Oily Skin, Psalm 103:2 Kjv, Sample Csv File For Users, American Bulldog Rescue Delaware, Tasty Crab Coupon, Joybird Replacement Cushions, Bowers And Wilkins T7 Charger, How To Use Drano On Double Sink, How To Return Ups Package,

You must be logged in to post a comment